Beckton Dickinson (BDX) agreed to invest $3 billion to onshore manufacturing of essential medical products, US President Donald Trump said Monday.
The plan includes over $1 billion to expand production in Nebraska for items such as needles made with American steel, Trump said on Truth Social.
The decision follows planned medical device tariffs scheduled to take effect by the end of the year, he added.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.